-1768251199374.webp&w=3840&q=75)
2025 MaTOS Lung | Session V | Locally Advanced NSCLC (Stage III)
Overview
Dr. Martin reviewed stage III NSCLC resectability, stressing N2 nodal patterns, induction response, minimally invasive surgery, and multidisciplinary decision-making.
Dr. Daly reviewed open questions on radiation plus immunotherapy in lung cancer, noting benefit of consolidation, mixed results with concurrency, and ongoing trials refining strategy.
The Q & A session stressed invasive mediastinal staging for larger or central lung tumors, role of EBUS/mediastinoscopy, frailty, PET nodes, and need for better trials.
Dr. Daly reviewed open questions on radiation plus immunotherapy in lung cancer, noting benefit of consolidation, mixed results with concurrency, and ongoing trials refining strategy.
The Q & A session stressed invasive mediastinal staging for larger or central lung tumors, role of EBUS/mediastinoscopy, frailty, PET nodes, and need for better trials.
Target Audience
Physicians
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Moderator: Lyudmila Bazhenova, MD
Speakers and Panelists:
Linda W. Martin, MD, MPH
Megan E. Daly, MD
Panelists:
Puneeth Iyengar, MD, PhD
Corey J. Langer, MD, FACP
Daniel Morgansztern, MD
Delvys Rodriguez Abreu, MD, PhD
Date of Release
January 8th, 2026
-1769196766441.webp&w=3840&q=75)
-1769196674841.webp&w=3840&q=75)